S
Simon Jones
Researcher at University of Manchester
Publications - 1100
Citations - 45394
Simon Jones is an academic researcher from University of Manchester. The author has contributed to research in topics: Haskell & Functional programming. The author has an hindex of 92, co-authored 1012 publications receiving 39886 citations. Previous affiliations of Simon Jones include University of California, Berkeley & Microsoft.
Papers
More filters
Large area validation of Himawari-8 fire active fire products
TL;DR: In this article, the authors presented results from a large area validation of these products to support wildfire surveillance and mapping using the geostationary Himawari-8 satellite and showed that the multi-resolution approach developed for AHI-FSA/BAT significantly improved the fire detection.
Backpack to work: towards practical mixin linking for Haskell
TL;DR: An evolution of the Backpack mixin package system which respects the division between package manager and compiler in the Haskell ecosystem: Backpack.
Journal Article
Consistent data recording across a health system and web-enablement allow service quality comparisons: online data for commissioning dermatology services.
TL;DR: All the national hospital dermatology treatment data in England is Web enabled combining it with locality data to provide a smart commissioning tool for local communities, which can be used to commission dermatology services in small areas.
National Audit of Hospital Mortality Annual Report 2019
Bridget Egan,Simon Jones,Gareth Clifford,Kevin Clarkson,Declan McKeown,Alan Egan,Deirdre Burke,Fionnola Kelly,Aoife Moroney Ward +8 more
TL;DR: There has been a continuing decrease in crude mortality trends for AMI, haemorrhagic stroke, pneumonia and heart failure over the past 10 years, however, ischaemic stroke and COPD have seen an increase in mortality rates in 2019 compared with 2018.
Posted ContentDOI
N-acetyl-L-leucine improves symptoms and functioning in GM2 Gangliosidosis (Tay-Sachs & Sandhoff)
Kyriakos Martakis,Kyriakos Martakis,Jens Claassen,Jordi Gascón-Bayarri,Nicolina Goldschagg,Andreas Hahn,Anhar Hassan,Anita Hennig,Simon Jones,Heather Lau,Susan Perlman,Reena Sharma,Susanne A. Schneider,Tatiana Bremova-Ertl +13 more
TL;DR: In this paper, the safety and efficacy of N-acetyl-L-leucine (NALL) on symptoms of pediatric (≥ 6 years) and adult patients with GM2 gangliosidosis was investigated.